Clinical Course After Radical Local Therapy for Oligo‐Recurrence of Nonsmall Cell Lung Cancer
Patients with EGFR mutations who develop oligo-recurrence should be monitored for disease progression. Re-enlargement of lesions after radical local therapy was associated with a poor prognosis. A good prognosis can be expected with active treatment, even in the event of disease progression.
Authors
- Yukitoshi Satoh (ORCID: https://orcid.org/0000-0002-2150-932X)
- Masashi Mikubo (ORCID: https://orcid.org/0000-0002-9914-421X)
- Dai Sonoda (ORCID: https://orcid.org/0000-0002-4439-5791)
- Raito Maruyama
- Satoru Tamagawa (ORCID: https://orcid.org/0000-0001-5783-8187)
- Kazu Shiomi (ORCID: https://orcid.org/0000-0002-3398-7732)
- Masahito Naito (ORCID: https://orcid.org/0000-0001-5699-8234)
- Yasuto Kondo (ORCID: https://orcid.org/0000-0003-0335-3154)
- S. Mitsuhashi
Institutions
- Kitasato University Medical Center (JP)
- Kitasato University (JP)
Publication Details
- Journal
- Journal of Surgical Oncology
- Published
- 2025-03-30
- DOI
- https://doi.org/10.1002/jso.28032
- Citations
- 2
- Primary Topic
- Lung Cancer Treatments and Mutations
- Type
- article
- Field-Weighted Citation Impact
- 3.04